Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from The United Laboratories International Holdings ( (HK:3933) ) is now available.
The United Laboratories International Holdings Limited has announced an interim cash dividend of RMB 0.16 per share for the six months ending June 30, 2024. This announcement reflects the company’s financial performance and commitment to returning value to shareholders, with key dates for the dividend process outlined, including an ex-dividend date of September 25, 2025, and a record date of September 30, 2025.
The most recent analyst rating on (HK:3933) stock is a Buy with a HK$18.00 price target. To see the full list of analyst forecasts on The United Laboratories International Holdings stock, see the HK:3933 Stock Forecast page.
More about The United Laboratories International Holdings
The United Laboratories International Holdings Limited operates in the pharmaceutical industry, focusing on the production and distribution of a wide range of pharmaceutical products. The company is known for its significant market presence in the manufacturing of antibiotics and other medical formulations.
Average Trading Volume: 17,533,933
Technical Sentiment Signal: Buy
Current Market Cap: HK$32.4B
See more insights into 3933 stock on TipRanks’ Stock Analysis page.